Zhengxiang Han

Xuzhou Medical College — China

Medicine · Health Sciences

13h-index833citations121works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(17), Cancer Immunotherapy and Biomarkers(16), Lung Cancer Research Studies(13), Hepatocellular Carcinoma Treatment and Prognosis(12), Lung Cancer Treatments and Mutations(12)

Publications121 total

Stage IIIB ROS1-Positive NSCLC management: crizotinib + surgery + TCM achieves exceptionally prolonged PFS (a case report)
Frontiers in Pharmacology·2026Open Access
Revealing differentially expressed genes between hypertrophic scars and normal skin tissues by bioinformatic analysis
Cutaneous and Ocular Toxicology·2025
Survival prognosis in advanced HER-2 negative gastric cancer treated with immunochemotherapy: A novel model
World Journal of Gastrointestinal Oncology·2025· 1 citedOpen Access
Anlotinib added to third generation EGFR tyrosine kinase inhibitor therapy for advanced NSCLC patients with oligo-progression: a retrospective study (ALTER-L058)
Frontiers in Pharmacology·2025Open Access
613 A clinical trial to evaluate the safety and preliminary efficacy results of CAR-macrophage in metastatic HER2-low expressing and HER2-positive solid tumors
Regular and Young Investigator Award Abstracts·2025· 1 citedOpen Access
Stability and Bifurcation in a Delayed Malaria Model with Threshold Control
Mathematics·2025Open Access
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
The Lancet·2025· 6 cited
Mechanism of Time-Dependent Deformation and Support Collaborative Failure in Water-Rich Red-Bed Soft Rock Tunnels
Applied Sciences·2025· 2 citedOpen Access
1556P Preliminary clinical results of CAR-macrophage in metastatic HER2-low expressing and HER2-positive solid tumors
Annals of Oncology·2025
Experimental study on the flame law and inhibition of corn starch explosion
Journal of Physics Conference Series·2025Open Access
Clinical significance of androgen receptor in unilateral invasive breast cancer in women
European journal of medical research·2025Open Access
CD99 is a potential diagnostic and immunological biomarker in pan-cancer
Discover Oncology·2025Open Access
Association of triglyceride-glucose index with long-term prognosis in advanced hepatocellular carcinoma patients receiving immunotherapy and targeted therapy
World Journal of Gastroenterology·2025· 2 citedOpen Access
Stress-Deformation Mechanisms of Tunnel Support in Neogene Red-Bed Soft Rock: Insights from Wireless Remote Monitoring and Spatiotemporal Analysis
Buildings·2025· 1 citedOpen Access
Engineering TLR7/8 Agonist‐Loaded and Tumor‐Anchored Gold Nanosensitizers for Enhanced Radioimmunotherapy
Small·2025· 2 cited
Impact of fibrinogen-to-albumin ratio on the long-term prognosis of patients with advanced HER2-negative gastric cancer receiving immunochemotherapy
World Journal of Gastrointestinal Oncology·2025Open Access
Roles and functions of tumor-infiltrating lymphocytes and tertiary lymphoid structures in gastric cancer progression
Frontiers in Immunology·2025· 6 citedOpen Access
Evaluating the safety and efficacy of CRISPR/AaCas12b <sup>Max</sup> -modified tumor infiltrating lymphocytes (GT300) as monotherapy in advanced solid tumors.
Journal of Clinical Oncology·2025· 1 cited
Pyrotinib in the first-line treatment of HER2-positive advanced breast cancer: Results from the PRETTY study.
Journal of Clinical Oncology·2025
Assessing the safety and efficacy of GT201: A first-in-class autologous tumor-infiltrating lymphocyte monotherapy in advanced solid tumors.
Journal of Clinical Oncology·2025· 1 cited
page 1 of 7Next →

Frequent Co-authors

Xiaobing Qin(10), Lansheng Zhang(8), Haonan Liu(7), Di Pan(7), Haonan Liu(6), Pengfei Qu(5), Luyao Ma(5), Caihong Li(4), Menghan Cao(4), Juanjuan Tang(4), Mengqiu Liu(3), Suchen Qu(3), Yue Zhu(3), Xia Zheng(3), Xiuping Du(3), Wenlou Liu(3), Hongmei Wang(3), Zhiyuan Xu(3), Xiaoxiao Chen(3), Baogang Liu(2)